Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers

NCT07097064 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

COMBINATION_PRODUCT: standard radiotherapy with chemotherapy
RADIATION: MRI-guided adaptive stereotactic radiotherapy (SMART)

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle